期刊文献+

高效液相色谱法测定注射用盐酸吉西他滨含量测定

下载PDF
导出
摘要 目的:建立高效液相色谱法测定注射用盐酸吉西他滨的含量。方法:采用高效液相色谱法,色谱柱:Aglea Venusil XBP C8 4.6×250mm 5um;流动相:以醋酸铵缓冲液(取醋酸铵3.85g加水800ml使溶解,加冰醋酸调p H值至5.7,加水1000ml)-甲醇(90:10)为流动相,检测波长268nm。结果:盐酸吉西他滨线性为y=944.25x+4608.5,r=0.9998,溶液在70.64 ng/ml^131.20ng/ml的浓度范围内线性关系良好;平均回收率为99.89%,RSD为0.53%(n=9),重复性RSD=0.12%(n=6);结论:该方法简便,线性、重复性好、准确度高,采用此方法能准确测定注射用盐酸吉西他滨含量。
作者 刘思佳
出处 《生物技术世界》 2016年第4期226-226,共1页 Biotech World
  • 相关文献

参考文献2

二级参考文献20

  • 1[1]Manegold C, Zatloukal P, Krejcy K, et al. Gemcitabine in non-small-cell lung cancer[J]. Invest New Drugs,2000,18(1):29-42.
  • 2[2]Merimsky O, Wigler N, Greif Y, et al. Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small-cell lung cancer: a phase Ⅱ study[J]. Anticancer Drugs,2000,11(2):117-121.
  • 3[3]Sandler AB, Nemunaitis J, Denham C, et al. Phase Ⅲ trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer[J]. J Clin Oncol,2000,18(1):122-130.
  • 4[4]Cardenal F, Lopez-Cabrerizo MP, Anton A, et al. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer[J]. J Clin Oncol,1999,17(1):12-18.
  • 5[5]Crino L, Scagliotti GV, Ricci S, et al. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase Ⅲ study of the Italian Lung Cancer Project[J]. J Clin Oncol1999,17(11):3522-3530.
  • 6[6]Schiller J, Harrington D, Sandler A, et al. A randomized phase III trial of fourchemotherapy regimens in advanced non-samll cell lung cancer (NSCLC)[J]. Am Soc Clin Oncol,2000,19:1-1.
  • 7[7]Kroep JR, Peters GJ, van Moorsel CJA, et al. Gemcitabine-cisplatin: A schedule finding study[J]. Ann Oncol,1999,10(12):1503-1510.
  • 8[8]Kroep JR, Giaccone G, Voorn DA, et al. Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer[J]. J Clin Oncol,1999,17(7):2190-2197.
  • 9[9]Sorensen JB, Stenbygaard LE, Dombernowsky P, et al. Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung Cancer[J]. Ann Oncol1999,10(9):1043-1049.
  • 10[10]Georgoulias V, Kouroussis C, Androulakis N, et al. Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase Ⅱ trial[J]. J Clin Oncol,1999,17(3):914-920.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部